| EPF091 | Media involvement in the fight against HIV and the discrimination suffered by LGBT people in Benin | E-poster | Representations of stigma: Social attitudes, media and public debate |
| EPF092 | Addressing hate speech towards men who have sex with men (MSM) in the Ugandan media sector | E-poster | Representations of stigma: Social attitudes, media and public debate |
| EPF093 | Media and HIV: Addressing sensational media reporting through empowering senior editors and media reporters. Experience from Uganda | E-poster | Representations of stigma: Social attitudes, media and public debate |
| EPB098 | Impact of HCV treatment on markers of kidney disease among persons with monoinfection and HCV/HIV co-infection | E-poster | Renal disease |
| EPB161 | Switching EFV/FTC/TDF to B/F/TAF or generic EFV/FTC/TDS in virologically suppressed adults with human immunodeficiency virus: a 96-week retrospective cohort | E-poster | Regimen simplification and switch studies |
| EPB162 | Integrase resistance emergence with dolutegravir/lamivudinewith prior HIV-1 suppression | E-poster | Regimen simplification and switch studies |
| EPB163 | Real-world HIV renal outcomes with TDF-to-TAF switch | E-poster | Regimen simplification and switch studies |
| EPB164 | Switching to dolutegravir/lamivudine two-drug regimen: durability and virologic outcomes in routine U.S. clinical care | E-poster | Regimen simplification and switch studies |
| EPB165 | Changes in inflammatory biomarkers and baseline variables after switching to dolutegravir/lamivudine (DTG/3TC) in 2 randomized clinical trials of virologically suppressed adults: 48-week pooled analysis | E-poster | Regimen simplification and switch studies |
| EPB166 | Rapid tenofovir-lamivudine-dolutegravir transition in Papua New Guinea: a virtual approach to antiretroviral prescriber refresher trainings during a global pandemic | E-poster | Regimen simplification and switch studies |